EORTC Quality of Life Group’s participation to ISOQOL 2024

We are delighted to announce the participation of the EORTC Quality of Life Group (QLG) to the ISOQOL Conference 2024, taking place from 13 to 16 October 2024 in Cologne, Germany. This year’s theme is “All different together: Showcasing variety of QOL research”.

This conference, organised by the International Society for Quality of Life Research (ISOQOL), brings the opportunity to explore the range of research conducted in the field of quality of life, including cancer patients and survivors. It is also noteworthy to announce that Dagmara Kuliś, Associate Head of the EORTC Quality of Life Department (QLD), is serving as a scientific co-Chair of the ISOQOL conference 2024.

On this occasion, the EORTC QLG is supporting the plenary session entitled “Back to basics: the concept of HRQL under a magnifying glass”, which will explore the evolution of the concept of health-related quality of life over the decades . Two well-known members of the QLG will take part in this session: Prof. Galina Velikova presenting the history of assessing cancer patients’ quality of life and Prof. Mogens Grønvold moderating the session. Furthermore, Dr Madeline Pe, Head of the EORTC QLD, will be chairing the symposium on “Use of Patient-reported Outcomes in Cancer Clinical Practice: Case Studies from Europe and the United States”, bringing the expertise from the EORTC in the field of quality of life in clinical trials in the discussion with, among others, Dr Bernhard Holzner and Prof. Lonneke van der Poll, both members of the EORTC QLG.

In addition, and importantly also, we are proud to showcase 13 abstracts to be presented, of which six are oral presentations. With these abstracts, members of the EORTC QLG and QLD will provide the audience with updates on projects carried out by the QLG, such as the development of new questionnaires for specific cancer types or patient groups, the EORTC Reference Values Database, or the digitisation of questionnaires. Finally, Claire Piccinin, from the EORTC QLD, will host a roundtable addressing “Item libraries for PRO assessment – opportunities, challenges, and future directions”.

For a detailed overview of the presentations’ abstracts, please consult the table below.

We look forward to seeing you at this conference!

For more information about the EORTC Quality of Life Group projects, please click here.

Oral Sessions

Poster Sessions

The Quality of Life Group (QLG) strives to improve health-related quality of life (HRQoL) of cancer patients, through dedicated research and the use of HRQoL measures within cancer clinical trials and clinical practice. HRQoL constitutes an important aspect of cancer research and care: it gives a voice to patients, putting their experience at the forefront. The QLG is part of the European Organisation for Research and Treatment of Cancer (EORTC).

For further information, please visit the QLG website: qol.eortc.org

The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium.

Caroline Hance (EORTC QLG)
caroline.hance@eortc.org